AgomAb Therapeutics NV (AGMB)

Last Closing Price: 12.65 (2026-07-02)

Income from Continuous Operations (Quarterly)

Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.

AgomAb Therapeutics NV (AGMB) Income from Continuous Operations data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
Income from Continuous Operations
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
137.17M
0.77M
35.71M
173.90M
21.03M
1.14M
4.77M
25.80M
148.10M
115.61M
148.10M
--
Cash Flow Statement Financials
-58.54M
-37.34M
-0.38M
193.99M
97.77M
-96.22M
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--